Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Lunai Bioworks ( (LNAI) ) has provided an announcement.
On April 28, 2026, Lunai Bioworks announced it had postponed its Special Meeting of Stockholders from May 4 to May 8, 2026, keeping the session in a virtual-only webcast format. The record date remains April 10, 2026, and previously submitted proxies will carry over unless changed or revoked by stockholders.
The delay follows advice that proxy materials sent on April 22, 2026 would not satisfy timing rules for broker discretionary voting under NYSE Rule 452 by the original date. By moving the meeting to May 8, the company aims to secure a quorum and enable brokers to vote on routine matters, including proposals tied to a reverse stock split that are important for sustaining Nasdaq listing compliance.
More about Lunai Bioworks
Lunai Bioworks, Inc., listed on Nasdaq under the ticker LNAI, operates in the biotechnology sector and is headquartered in Sacramento, California. The company is currently engaging its shareholder base through virtual stockholder meetings and proxy solicitations, with an apparent focus on maintaining compliance with Nasdaq’s continued listing standards, including through potential capital structure actions.
Average Trading Volume: 19,658,134
Technical Sentiment Signal: Strong Sell
Current Market Cap: $11.25M
See more insights into LNAI stock on TipRanks’ Stock Analysis page.